Our Research Priorities

Our research interests reflect a commitment to encouraging scientific investigation, supporting collaboration and advancing knowledge that may contribute to earlier diagnosis, better treatments and, ultimately, a cure.

Our Research Focus

Research into Multiple System Atrophy involves many different scientific and clinical disciplines.

National MSA Research is particularly interested in areas that could help improve understanding of the condition and create meaningful benefits for people living with MSA.

The following areas represent important directions for research that our organisation aims to encourage and consider when evaluating future opportunities.

1. Understanding the Causes of MSA

One of the most important challenges in MSA research is understanding why the condition develops.

MSA is associated with abnormal accumulation of a protein called alpha-synuclein in certain cells of the nervous system.

Researchers are investigating the biological processes involved in this accumulation and how they contribute to damage within the brain and nervous system.

Improving our understanding of these processes may help identify potential targets for future treatments.

Research interests in this area include disease mechanisms, cellular changes, genetic and environmental influences, and the progression of neurological damage.

2. Earlier and More Accurate Diagnosis

Diagnosing Multiple System Atrophy can be challenging, particularly during the early stages.

Some symptoms overlap with Parkinson’s disease and other neurological conditions, making accurate diagnosis more difficult.

Researchers are investigating ways to improve the identification and diagnosis of MSA.

Areas of interest include:

• Improved diagnostic methods.
• Biological markers, commonly known as biomarkers.
• Advanced medical imaging.
• Clinical assessment techniques.
• Methods for distinguishing MSA from similar neurological conditions.

Earlier and more reliable diagnosis could help patients receive appropriate care sooner and may improve opportunities to participate in relevant research.

3. Developing Better Treatments

There is currently no cure for Multiple System Atrophy and no established treatment that stops its progression.

Developing more effective treatments remains a major objective of MSA research.

Scientists are investigating approaches that may target underlying disease processes rather than only managing symptoms.

Potential research directions include new therapeutic compounds, treatments targeting alpha-synuclein-related processes and other approaches designed to protect or preserve neurological function.

These approaches remain areas of scientific investigation and should not be considered proven treatments unless supported by appropriate clinical evidence and regulatory approval.

4. Understanding Disease Progression

Multiple System Atrophy can progress differently between individuals.

Research into how the condition develops and changes over time may help improve clinical understanding, patient care and the design of future studies.

Important areas include identifying factors associated with disease progression, understanding different patterns of symptoms and improving methods used to measure changes over time.

This information may also help researchers assess whether experimental treatments are having a meaningful effect.

5. Improving Quality of Life

While research continues towards more effective treatments and a cure, improving quality of life for people currently living with MSA remains important.

Research into symptom management and supportive care may help patients and families navigate the challenges associated with the condition.

Areas of interest include mobility, balance, communication, swallowing, autonomic symptoms, sleep, emotional wellbeing and everyday independence.

We recognise that research outcomes should consider not only scientific measurements but also the experiences and needs of individuals affected by MSA.

6. Clinical Research and Trials

Clinical research plays an important role in understanding diseases and evaluating potential treatments.

Clinical trials may investigate the safety and effectiveness of new therapies, diagnostic approaches or other interventions.

National MSA Research supports the importance of appropriately designed, ethically reviewed clinical research.

We are interested in encouraging connections between researchers, healthcare professionals and the wider MSA community where appropriate.

Participation in clinical research is voluntary and subject to individual eligibility requirements, informed consent and the relevant study’s ethical approvals.

National MSA Research does not guarantee access to clinical trials or experimental treatments.

7. Research Collaboration

Multiple System Atrophy is a rare condition, making collaboration especially valuable.

Bringing together researchers, clinicians, institutions and charitable organisations can help encourage the sharing of scientific knowledge and expertise.

National MSA Research recognises the importance of both Australian and international cooperation.

We aim to encourage appropriate collaboration that contributes to a better understanding of MSA and supports meaningful scientific progress.

Potential collaborations and research proposals are subject to organisational consideration, governance requirements and available resources.

The Importance of Research Governance

Supporting research requires careful consideration of scientific quality, potential impact, ethical standards and financial responsibility.

National MSA Research intends to evaluate research opportunities in accordance with its charitable objectives and appropriate organisational approval processes.

Where relevant, consideration may be given to scientific merit, research methodology, feasibility, patient relevance and the potential contribution to existing knowledge.

The research areas described on this page do not represent confirmed grants, approved projects or guaranteed funding commitments.

Specific funding decisions will be made separately and announced when appropriate.

Putting Patients and Families at the Centre

Behind every research question are people and families affected by Multiple System Atrophy.

We believe that their experiences and perspectives can provide valuable insights into the challenges of living with the condition.

Research should aim to produce meaningful improvements in understanding, diagnosis, treatment and care.

By recognising the needs of patients, carers and families, we hope to contribute to a research environment that remains focused on the people it ultimately seeks to help.

Supporting the Future of MSA Research

Scientific progress often requires long-term commitment, collaboration and sustained investment.

Through fundraising, awareness initiatives, partnerships and community support, National MSA Research works towards creating opportunities to advance research into Multiple System Atrophy.

Our long-term ambition is to contribute to a future where MSA can be diagnosed earlier, treated more effectively and ultimately cured.

Get Involved in Supporting Research

There are many ways to help support the mission of National MSA Research.

Individuals, families, businesses and community organisations can contribute through donations, fundraising activities, volunteering, partnerships and awareness initiatives.

Researchers and healthcare professionals interested in appropriate collaboration are also welcome to contact our organisation.

Contact National MSA Research

For general enquiries about our research interests or opportunities to collaborate, please contact:

National MSA Research
Rare Neurological Disease Research Ltd
ABN: 55 681 229 032

Email: info@nationalmsaresearch.org.au
Website: www.nationalmsaresearch.org.au

Together, through scientific discovery, collaboration and community support, we can work towards a future without Multiple System Atrophy.